Concept information
Terme préférentiel
Neostigmine
Type
-
mesh:Descriptor
Définition
- A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
Concept générique
Synonyme(s)
- 005SYP50G5
- 114-80-7 (bromide)
- 3982TWQ96G
- 51-60-5 (methyl sulfate)
- 59-99-4 (Neostigmine)
- 98IMH7M386
- Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
- Proserine
- Prozerin
- Synstigmin
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Action(s) pharmacologique(s)
Traductions
-
français
-
005SYP50G5
-
114-80-7 (bromide)
-
3982TWQ96G
-
51-60-5 (methyl sulfate)
-
59-99-4 (Neostigmine)
-
98IMH7M386
-
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
URI
http://data.loterre.fr/ark:/67375/JVR-J4NCDGZ6-F
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}